Current Trends in Development of Liposomes for Targeting Bacterial Biofilms

Biofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomall...

Full description

Bibliographic Details
Main Authors: Zora Rukavina, Željka Vanić
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Pharmaceutics
Subjects:
Online Access:http://www.mdpi.com/1999-4923/8/2/18
id doaj-5cb614e3d6844876a87ffeccc0c9f8cf
record_format Article
spelling doaj-5cb614e3d6844876a87ffeccc0c9f8cf2020-11-25T01:30:18ZengMDPI AGPharmaceutics1999-49232016-05-01821810.3390/pharmaceutics8020018pharmaceutics8020018Current Trends in Development of Liposomes for Targeting Bacterial BiofilmsZora Rukavina0Željka Vanić1Department of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, CroatiaDepartment of Pharmaceutical Technology, Faculty of Pharmacy and Biochemistry, University of Zagreb, A. Kovačića 1, 10000 Zagreb, CroatiaBiofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomally-associated nanomicrobials, presents a promising approach for improved drug delivery to bacterial cells and biofilms. Versatile manipulations of liposomal physicochemical properties, such as the bilayer composition, membrane fluidity, size, surface charge and coating, enable development of liposomes with desired pharmacokinetic and pharmacodynamic profiles. This review attempts to provide an unbiased overview of investigations of liposomes destined to treat bacterial biofilms. Different strategies including the recent advancements in liposomal design aiming at eradication of existing biofilms and prevention of biofilm formation, as well as respective limitations, are discussed in more details.http://www.mdpi.com/1999-4923/8/2/18liposomesbiofilmantimicrobialinfectiondrug deliveryphysicochemical properties
collection DOAJ
language English
format Article
sources DOAJ
author Zora Rukavina
Željka Vanić
spellingShingle Zora Rukavina
Željka Vanić
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
Pharmaceutics
liposomes
biofilm
antimicrobial
infection
drug delivery
physicochemical properties
author_facet Zora Rukavina
Željka Vanić
author_sort Zora Rukavina
title Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
title_short Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
title_full Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
title_fullStr Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
title_full_unstemmed Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
title_sort current trends in development of liposomes for targeting bacterial biofilms
publisher MDPI AG
series Pharmaceutics
issn 1999-4923
publishDate 2016-05-01
description Biofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomally-associated nanomicrobials, presents a promising approach for improved drug delivery to bacterial cells and biofilms. Versatile manipulations of liposomal physicochemical properties, such as the bilayer composition, membrane fluidity, size, surface charge and coating, enable development of liposomes with desired pharmacokinetic and pharmacodynamic profiles. This review attempts to provide an unbiased overview of investigations of liposomes destined to treat bacterial biofilms. Different strategies including the recent advancements in liposomal design aiming at eradication of existing biofilms and prevention of biofilm formation, as well as respective limitations, are discussed in more details.
topic liposomes
biofilm
antimicrobial
infection
drug delivery
physicochemical properties
url http://www.mdpi.com/1999-4923/8/2/18
work_keys_str_mv AT zorarukavina currenttrendsindevelopmentofliposomesfortargetingbacterialbiofilms
AT zeljkavanic currenttrendsindevelopmentofliposomesfortargetingbacterialbiofilms
_version_ 1725092217773621248